Actively Recruiting

Age: 18Years +
FEMALE
Healthy Volunteers
NCT06698679

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

Led by Shengjing Hospital · Updated on 2024-11-21

1000

Participants Needed

1

Research Sites

363 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study investigates plasma metabolites to clarify the relationship between these metabolites and breast cancer, aiming to identify valuable biomarkers. Furthermore, by incorporating clinical information-such as cancer stage, type, treatment outcomes, and prognosis-into prospective studies, the research seeks to further examine the correlation between plasma metabolites, treatment efficacy, and prognosis.

CONDITIONS

Official Title

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women without breast cancer or other malignancies (Cohort 1 control group)
  • Women with histologically confirmed carcinoma in situ or invasive breast cancer; no prior treatment; no distant metastasis; no other malignant tumors (Cohort 1 case group)
  • Women pathologically diagnosed with breast cancer; treatment naive; planned to receive standard neoadjuvant therapy; ECOG performance status 0-1; at least one measurable lesion per RECIST v1.1 (Cohort 2)
  • Women who have completed breast cancer treatment and have been discharged (Cohort 3)
Not Eligible

You will not qualify if you...

  • Breast cancer not confirmed by histology
  • Breast cancer with distant metastases
  • Breast cancer combined with other malignant tumors
  • Participation in other clinical trials within the past month, except observational or non-interventional trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China, 110004

Actively Recruiting

Loading map...

Research Team

L

Liu Hua, Ph. D

CONTACT

L

Liu Cai Gang, Ph. D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer | DecenTrialz